Last update 13 Nov 2024

Simcha IL-18, Inc.

Private Company|
Delaware, United States

Overview

Tags

Neoplasms
Skin and Musculoskeletal Diseases
Other Diseases
Biological products
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Hemic and Lymphatic Diseases1
Top 5 Drug TypeCount
Biological products1
Monoclonal antibody1
Top 5 TargetCount
IL-18(Interleukin 18)1
PD-1(Programmed cell death protein 1)1

Related

2
Drugs associated with Simcha IL-18, Inc.
Vevoctadekin
Target
IL-18
Mechanism
IL-18 stimulants
Active Org.
Simcha IL-18, Inc. [+1]
Originator Org.-
Active Indication
Advanced Malignant Solid Neoplasm [+8]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
WO2024158840
Patent Mining
Target
PD-1
Mechanism-
Active Org.
Simcha IL-18, Inc.
Originator Org.
Simcha IL-18, Inc.
Active Indication
Neoplasms [+1]
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Simcha IL-18, Inc.
NCT04787042 / Active, not recruitingPhase 1/2
A First-In-Human Phase 1/2 Open-Label Study of Intravenous ST-067, Subcutaneous ST-067 With or Without Obinutuzumab Pre-Treatment, and ST-067 in Combination With Pembrolizumab in Subjects With Advanced Solid Malignancies
100 Clinical Results associated with Simcha IL-18, Inc.
Login to view more data
0 Patents (Medical) associated with Simcha IL-18, Inc.
Login to view more data
100 Deals associated with Simcha IL-18, Inc.
Login to view more data
100 Translational Medicine associated with Simcha IL-18, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
Phase 2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Vevoctadekin
 ( IL-18 )		Non-Small Cell Lung Cancer
More
Phase 1/2
WO2024158840
 ( PD-1 )Patent Mining		Neoplasms
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free